| NCT ID | NCT06187025 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Bordeaux |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-02-07 |
| Primary Completion | 2026-08-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2024-02-07 with a primary completion date of 2026-08-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Modifiable stroke risk-factors, which include poor lifestyle habits, account for 90 % of the risk of stroke. Disability Adjusted Life Years (DALYs) related to cerebrovascular disorders rely on three main factors, including the severity of stroke-related symptoms, the occurrence of stroke complications, and stroke recurrences. Stroke complications and the risk of stroke recurrence are highly dependent on the control of vascular risk factors. Thus, the secondary prevention of stroke involves profound lifestyle modifications including substance use cessation and diet changes.
Eligibility Criteria
Inclusion Criteria: * Male or female * At least 18 years of age and younger than 80 years; * Recent (≤ 15 days) clinically symptomatic ischemic or hemorrhagic stroke documented through brain imaging (CT or MRI) or a Transient Ischemic Attack with an ABCD2 score ≥ 4; * Returning to the Bordeaux Hospital neurovascular unit for the standard care 3-months post-stroke follow-up visit; * National Institute Health Stroke Scale (NIHSS) \< 15; * modified Rankin scale ≤ 4; * No severe cognitive impairment as defined by the neurologist; * Written informed consent by the patient; * Coverage by the French National Health Insurance. For the feasibility study assessing the acceptability of the eHealth device to optimize stroke secondary prevention, additional inclusion criteria will be the ability to use a smartphone and living in an area with internet coverage. Exclusion Criteria: * Subarachnoid hemorrhage; Dementia syndrome or other neurologic disorder; * Severe aphasia (NIHSS item 9 ≥ 2) and/or Severe visual impairment interfering with the completion of evaluations; * Severely impaired physical and/or mental health that, according to the neurologist, may affect the participant's capacity to participate in the study; * Pregnancy or breastfeeding; * Inability to read French; * Individuals under legal protection or unable to personally express their consent * Participation in another protocol modifying the patient's follow-up status
Contact & Investigator
Igor Sibon
PRINCIPAL INVESTIGATOR
University Hospital, Bordeaux
Frequently Asked Questions
Who can join the NCT06187025 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06187025 currently recruiting?
Yes, NCT06187025 is actively recruiting participants. Contact the research team at igor.sibon@chu-bordeaux.fr for enrollment information.
Where is the NCT06187025 trial being conducted?
This trial is being conducted at Bordeaux, France.
Who is sponsoring the NCT06187025 clinical trial?
NCT06187025 is sponsored by University Hospital, Bordeaux. The principal investigator is Igor Sibon at University Hospital, Bordeaux. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.